Pharmaids Pharmaceuticals Limited | Small-cap | Healthcare
₹62.00
-0.43%
| Pharmaids Stock Comparison:
Pharmaids vs Sun PharmaceuticalPharmaids vs Divi's LaboratoriesPharmaids vs Sun Pharma AdvancedPharmaids vs Aarti DrugsPharmaids vs Sequent ScientificPharmaids vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 66.6M
Gross Profit 31.6M 47.39%
Operating Income -60.2M -90.28%
Net Income -53.2M -79.77%
EPS (Diluted) ₹-1.41

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 648.1M
Shareholders Equity 550.4M
Debt to Equity 1.18

Cash Flow Metrics

Operating Cash Flow -1.1M
Free Cash Flow 2.4M

Revenue & Profitability Trend

Pharmaids Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i194.5M146.0M039.4M85.5M
Cost of Goods Sold i124.0M129.0M8.9M35.7M81.6M
Gross Profit i70.4M17.0M-8.9M3.7M3.9M
Gross Margin % i36.2%11.6%0.0%9.3%4.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-13.9M2.1M609.6K418.7K
Other Operating Expenses i66.4M34.3M74.8M533.4K1.0M
Total Operating Expenses i66.4M48.2M76.9M1.1M1.5M
Operating Income i-152.0M-140.1M-99.0M1.3M732.0K
Operating Margin % i-78.1%-95.9%0.0%3.2%0.9%
Non-Operating Items
Interest Income i-2.2M0--
Interest Expense i20.9M15.4M000
Other Non-Operating Income-----
Pre-tax Income i-172.8M-156.2M-99.1M1.4M884.3K
Income Tax i-37.7M-37.8M-23.5M-48.8K-48.8K
Effective Tax Rate % i0.0%0.0%0.0%-3.5%-5.5%
Net Income i-135.1M-118.4M-75.6M1.5M933.1K
Net Margin % i-69.4%-81.1%0.0%3.7%1.1%
Key Metrics
EBITDA i-126.5M-115.0M-98.9M1.4M1.4M
EPS (Basic) i₹-3.05₹-3.51₹-5.86₹0.14₹0.09
EPS (Diluted) i₹-3.05₹-3.51₹-5.86₹0.14₹0.09
Basic Shares Outstanding i3533311522718464128961661031123410311234
Diluted Shares Outstanding i3533311522718464128961661031123410311234

Income Statement Trend

Pharmaids Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i21.4M48.0M127.5M4.1M2.0M
Short-term Investments i--33.1M--
Accounts Receivable i31.3M26.8M20.5M13.4M2.8M
Inventory i121.8M35.9M08.9M3.7M
Other Current Assets48.5M-1.0K1.0K339.0K106.0K
Total Current Assets i223.1M135.3M183.2M26.7M8.6M
Non-Current Assets
Property, Plant & Equipment i446.5M10.7M1.1M4.2M4.2M
Goodwill i633.8M633.8M0--
Intangible Assets i5.5M5.5M---
Long-term Investments-----
Other Non-Current Assets3.2M-1.0K1.2M--
Total Non-Current Assets i975.5M778.1M62.7M84.4M82.6M
Total Assets i1.2B913.4M245.8M111.1M91.2M
Liabilities
Current Liabilities
Accounts Payable i163.2M51.2M18.8M23.1M5.0M
Short-term Debt i58.6M24.8M000
Current Portion of Long-term Debt-----
Other Current Liabilities15.4M614.0K472.0K1.3M869.0K
Total Current Liabilities i287.1M115.8M21.2M24.4M5.9M
Non-Current Liabilities
Long-term Debt i331.2M60.5M000
Deferred Tax Liabilities i--000
Other Non-Current Liabilities-1.0K-1.0K-1.0K--
Total Non-Current Liabilities i361.0M92.7M-1.0K00
Total Liabilities i648.1M208.4M21.2M24.4M5.9M
Equity
Common Stock i352.7M352.7M214.4M102.7M102.7M
Retained Earnings i--139.3M-98.9M-23.3M-24.8M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i550.4M705.0M224.6M86.7M85.3M
Key Metrics
Total Debt i389.7M85.3M000
Working Capital i-64.1M19.6M161.9M2.3M2.7M

Balance Sheet Composition

Pharmaids Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-172.8M-156.2M-99.1M1.4M884.3K
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-125.6M17.2M62.6M-2.6M-2.2M
Operating Cash Flow i-278.1M-131.9M-36.4M-1.2M-1.3M
Investing Activities
Capital Expenditures i-122.6M-227.2M-16.7M0-15.0K
Acquisitions i0-524.8M-32.7M--
Investment Purchases i---32.7M-0
Investment Sales i----0
Investing Cash Flow i-122.6M-752.0M-82.1M4.7M4.5M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i327.0M15.3M0-0
Debt Repayment i-49.1M-18.0M0-0
Financing Cash Flow i258.2M795.6M213.1M00
Free Cash Flow i-264.7M-334.8M-56.9M-2.6M4.0M
Net Change in Cash i-142.6M-88.3M94.6M3.5M3.2M

Cash Flow Trend

Pharmaids Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 2,023.33
Price to Book 3.71
Price to Sales 10.23
PEG Ratio 23.66

Profitability Ratios

Profit Margin -61.01%
Operating Margin -90.28%
Return on Equity -19.58%
Return on Assets -8.99%

Financial Health

Current Ratio 0.78
Debt to Equity 70.81
Beta 0.38

Per Share Data

EPS (TTM) ₹-3.70
Book Value per Share ₹16.72
Revenue per Share ₹6.06

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
pharmaid2.2B2,023.333.71-19.58%-61.01%70.81
Sun Pharmaceutical 3.9T38.005.4715.08%19.29%3.26
Divi's Laboratories 1.6T70.8710.9114.64%23.89%0.03
Sun Pharma Advanced 47.4B-13.85-21.83157.88%-53.22%-1.24
Aarti Drugs 43.0B22.813.1412.28%7.80%44.92
Sequent Scientific 44.4B155.796.302.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.